Skip to content
Webe Honey – Lifestyle
Home
Sample Page
Author:
Helus Pharma
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
June 24, 2026
Helus Pharma™ Announces US$50 Million Underwritten Offering
June 24, 2026
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
June 11, 2026
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
June 1, 2026
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
April 30, 2026
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
April 23, 2026
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
April 20, 2026
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
April 16, 2026
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
March 12, 2026